These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35172473)

  • 41. mmsig: a fitting approach to accurately identify somatic mutational signatures in hematological malignancies.
    Rustad EH; Nadeu F; Angelopoulos N; Ziccheddu B; Bolli N; Puente XS; Campo E; Landgren O; Maura F
    Commun Biol; 2021 Mar; 4(1):424. PubMed ID: 33782531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An miRNA signature associated with tumor mutation burden in endometrial cancer.
    Zhou H; Chen L; Qin M; Lei Y; Li T; Li H; Cheng X
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33141168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unravelling the Sequential Interplay of Mutational Mechanisms during Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia.
    Antić Ž; Lelieveld SH; van der Ham CG; Sonneveld E; Hoogerbrugge PM; Kuiper RP
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33540666
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility.
    Wilmott JS; Johansson PA; Newell F; Waddell N; Ferguson P; Quek C; Patch AM; Nones K; Shang P; Pritchard AL; Kazakoff S; Holmes O; Leonard C; Wood S; Xu Q; Saw RPM; Spillane AJ; Stretch JR; Shannon KF; Kefford RF; Menzies AM; Long GV; Thompson JF; Pearson JV; Mann GJ; Hayward NK; Scolyer RA
    Int J Cancer; 2019 Mar; 144(5):1049-1060. PubMed ID: 30178487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutational signature distribution varies with DNA replication timing and strand asymmetry.
    Tomkova M; Tomek J; Kriaucionis S; Schuster-Böckler B
    Genome Biol; 2018 Sep; 19(1):129. PubMed ID: 30201020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Somatic mutational signatures in polyposis and colorectal cancer.
    Grolleman JE; Díaz-Gay M; Franch-Expósito S; Castellví-Bel S; de Voer RM
    Mol Aspects Med; 2019 Oct; 69():62-72. PubMed ID: 31108140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A semiparametric kernel independence test with application to mutational signatures.
    Lee D; Zhu B
    J Am Stat Assoc; 2021; 116(536):1648-1661. PubMed ID: 35515712
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.
    Chalmers ZR; Connelly CF; Fabrizio D; Gay L; Ali SM; Ennis R; Schrock A; Campbell B; Shlien A; Chmielecki J; Huang F; He Y; Sun J; Tabori U; Kennedy M; Lieber DS; Roels S; White J; Otto GA; Ross JS; Garraway L; Miller VA; Stephens PJ; Frampton GM
    Genome Med; 2017 Apr; 9(1):34. PubMed ID: 28420421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
    Cho RJ; Alexandrov LB; den Breems NY; Atanasova VS; Farshchian M; Purdom E; Nguyen TN; Coarfa C; Rajapakshe K; Prisco M; Sahu J; Tassone P; Greenawalt EJ; Collisson EA; Wu W; Yao H; Su X; Guttmann-Gruber C; Hofbauer JP; Hashmi R; Fuentes I; Benz SC; Golovato J; Ehli EA; Davis CM; Davies GE; Covington KR; Murrell DF; Salas-Alanis JC; Palisson F; Bruckner AL; Robinson W; Has C; Bruckner-Tuderman L; Titeux M; Jonkman MF; Rashidghamat E; Lwin SM; Mellerio JE; McGrath JA; Bauer JW; Hovnanian A; Tsai KY; South AP
    Sci Transl Med; 2018 Aug; 10(455):. PubMed ID: 30135250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sequence dependencies and mutation rates of localized mutational processes in cancer.
    Poulsgaard GA; Sørensen SG; Juul RI; Nielsen MM; Pedersen JS
    Genome Med; 2023 Aug; 15(1):63. PubMed ID: 37592287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nucleotide Weight Matrices Reveal Ubiquitous Mutational Footprints of AID/APOBEC Deaminases in Human Cancer Genomes.
    Rogozin IB; Roche-Lima A; Lada AG; Belinky F; Sidorenko IA; Glazko GV; Babenko VN; Cooper DN; Pavlov YI
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30759888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer.
    Nik-Zainal S; Wedge DC; Alexandrov LB; Petljak M; Butler AP; Bolli N; Davies HR; Knappskog S; Martin S; Papaemmanuil E; Ramakrishna M; Shlien A; Simonic I; Xue Y; Tyler-Smith C; Campbell PJ; Stratton MR
    Nat Genet; 2014 May; 46(5):487-91. PubMed ID: 24728294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression.
    Ashley CW; Da Cruz Paula A; Kumar R; Mandelker D; Pei X; Riaz N; Reis-Filho JS; Weigelt B
    Gynecol Oncol; 2019 Jan; 152(1):11-19. PubMed ID: 30415991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unraveling the genomic landscape of colorectal cancer through mutational signatures.
    Díaz-Gay M; Alexandrov LB
    Adv Cancer Res; 2021; 151():385-424. PubMed ID: 34148618
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topography of mutational signatures in non-small cell lung cancer: emerging concepts, clinical applications, and limitations.
    Jayakrishnan R; Kwiatkowski DJ; Rose MG; Nassar AH
    Oncologist; 2024 Jun; ():. PubMed ID: 38907669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutational signature SBS8 predominantly arises due to late replication errors in cancer.
    Singh VK; Rastogi A; Hu X; Wang Y; De S
    Commun Biol; 2020 Aug; 3(1):421. PubMed ID: 32747711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Negative Selection Allows DNA Mismatch Repair-Deficient Mouse Fibroblasts
    Zhang L; Lee M; Hao X; Ehlert J; Chi Z; Jin B; Maslov AY; Barabási AL; Hoeijmakers JHJ; Edelmann W; Vijg J; Dong X
    bioRxiv; 2024 May; ():. PubMed ID: 38766154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An Exon Signature to Estimate the Tumor Mutational Burden of Right-sided Colon Cancer Patients.
    Guo W; Fu Y; Jin L; Song K; Yu R; Li T; Qi L; Gu Y; Zhao W; Guo Z
    J Cancer; 2020; 11(4):883-892. PubMed ID: 31949492
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical Outcome-Related Mutational Signatures Identified by Integrative Genomic Analysis in Nasopharyngeal Carcinoma.
    Dai W; Chung DL; Chow LK; Yu VZ; Lei LC; Leong MM; Chan CK; Ko JM; Lung ML
    Clin Cancer Res; 2020 Dec; 26(24):6494-6504. PubMed ID: 32988965
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of cancer mutational signatures on transcription factor motifs in the human genome.
    Yiu Chan CW; Gu Z; Bieg M; Eils R; Herrmann C
    BMC Med Genomics; 2019 May; 12(1):64. PubMed ID: 31109337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.